Over 90 Total Lots Up For Auction at One Location - WA 04/08

Measuring malignancy via the sugar levels of 'cellular slime' with MRI

by Gus Iversen, Editor in Chief | March 30, 2015
MRI
Normal cells (left) have far
more sugar attached to
mucin proteins than do
cancerous cells (right).
Cancerous cells shed sugar from their outer membranes. By visualizing cellular sugar quantities with MRI, researchers from Johns Hopkins University may be paving the way to a no-biopsy-needed cancer diagnosis.

While imaging has always played a crucial role in observing tumors, this would be the first example of visually determining the nature of the cells — malignant or benign — directly and non-invasively.

The researchers published their findings in a report from March 27th in the journal Nature Communications. Although they have currently only tested their hypothesis on test tube-grown cells and mice, they are hopeful that more clinical benefits can be taken from the study.
stats
DOTmed text ad

New Fully Configured 80-slice CT in 2 weeks with Software Upgrades for Life

For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.

stats
"We think this is the first time scientists have found a use in imaging cellular slime," said Dr. Jeff Blute, a professor of radiology and radiological science at the Institute for Cell Engineering at Johns Hopkins, and study author.

"As cells become cancerous, some proteins on their outer membranes shed sugar molecules and become less slimy, perhaps because they're crowded closer together. If we tune the MRI to detect sugar attached to a particular protein, we can see the difference between normal and cancerous cells," Blute continued.

The researchers believe that by being able to identify the cancer through its own properties they could theoretically image the entire tumor, something that contrast-aided imaging does not always allow for. Among the practical uses of such imaging capabilities would be chemotherapy-response monitoring, early cancer detection, and guiding biopsies to the most malignant part of a tumor — if not replacing the biopsy entirely.

The next phase in the team's research will involve testing its hypothesis by using MRI sugar imaging to distinguish cancerous tumors from benign masses in mice.

You Must Be Logged In To Post A Comment